Episode #14 - These hamsters have birthed billions for biotech
Aug 3, 2016 - 00:20:43
Radio and PodcastLive Radio & Podcasts
Science & Medicine
UPDATE: What happened at the FDA panel review of one Duchenne drug?
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
Related Episodes
Continue listening to more episodes from Signal.
Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them
Jul 13, 2016 - 00:24:46
Episode #12 - Before you pop that Tylenol, listen to this podcast
Jun 15, 2016 - 00:25:37
Episode #10 - Cancer is a low-down, dirty gangster ninja
May 4, 2016 - 00:23:04
Episode #9 - What should you most fear? Sharks, killer snails or the flu?
Apr 18, 2016 - 00:23:09
SIgnal takes a mini-break for a special reason
Feb 11, 2016 - 00:03:07
Episode #6 - Choosing scientific sides in the fight against Alzheimer's
Jan 28, 2016 - 00:20:12